Janus Henderson Group PLC Phathom Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.2 - $15.5 $5.64 Million - $14.1 Million	-909,230 Reduced 45.43%	1,092,212 $9.22 Million
Q1 2022 May 16, 2022	BUY	$11.55 - $20.06 $1.85 Million - $3.21 Million	160,085 Added 8.69%	2,001,442 $27.2 Million
Q4 2021 Feb 14, 2022	SELL	$17.83 - $33.15 $1.9 Million - $3.54 Million	-106,645 Reduced 5.47%	1,841,357 $36.2 Million
Q3 2021 Nov 16, 2021	SELL	$30.69 - $36.83 $111,466 - $133,766	-3,632 Reduced 0.19%	1,948,002 $62.5 Million
Q2 2021 Aug 16, 2021	SELL	$32.66 - $39.87 $91,905 - $112,194	-2,814 Reduced 0.14%	1,951,634 $66.1 Million
Q1 2021 May 17, 2021	BUY	$33.86 - $48.68 $542,166 - $779,464	16,012 Added 0.83%	1,954,448 $73.4 Million
Q4 2020 Feb 16, 2021	BUY	$33.22 - $50.26 $12.3 Million - $18.6 Million	369,640 Added 23.56%	1,938,436 $64.4 Million
Q3 2020 Nov 16, 2020	SELL	$29.24 - $40.19 $288,978 - $397,197	-9,883 Reduced 0.63%	1,568,796 $57.5 Million
Q2 2020 Aug 14, 2020	SELL	$25.06 - $54.6 $2.23 Million - $4.85 Million	-88,898 Reduced 5.33%	1,578,679 $52 Million
Q1 2020 May 14, 2020	BUY	$24.65 - $42.83 $4.93 Million - $8.57 Million	200,115 Added 13.64%	1,667,577 $42.2 Million
Q4 2019 Feb 18, 2020	BUY	$18.59 - $37.67 $27.3 Million - $55.3 Million	1,467,462 New	1,467,462 $43.6 Million

144

73.6M

42.3K

45.7K

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $294M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.